KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by KalVista Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for KalVista Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Pereira Brian JG | Director | – | Jun 11, 2026 | 2 |
| Unkart Edward W | Director | – | Jun 11, 2026 | 2 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | 0 | Jun 11, 2026 | 14 |
| Reid Laurence | Director | – | Jun 11, 2026 | 1 |
| Stuart Nancy | Director | – | Jun 11, 2026 | 2 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | 0 | Jun 11, 2026 | 10 |
| Fairey William | Director | – | Jun 11, 2026 | 2 |
| Piekos Brian | Chief Financial Officer | 0 | Jun 11, 2026 | 6 |
| Sweeny Nicole | Chief Commercial Officer | 0 | Jun 11, 2026 | 7 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | 0 | Jun 11, 2026 | 10 |
| Sensenig Bethany | Director | – | Jun 11, 2026 | 2 |
| Treanor Patrick | Director | – | Jun 11, 2026 | 2 |
| Arif Bilal | Chief Operations Officer | – | Jun 11, 2026 | 3 |
| Koh Bong Y | 10% Owner | 5,089,354Indirect | Mar 27, 2026 | 1 |
| Shah Nimish P | 10% Owner | 5,089,354Indirect | Mar 27, 2026 | 1 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 5,089,354Indirect | Mar 27, 2026 | 1 |
| VHCP Management III, LLC | 10% Owner | 5,089,354Indirect | Mar 27, 2026 | 1 |
| VHCP Co-Investment Holdings III, LLC | 10% Owner | 5,089,354Indirect | Mar 27, 2026 | 1 |
| Venrock Healthcare Capital Partners EG, L.P. | 10% Owner | 5,089,354Indirect | Mar 27, 2026 | 1 |
| VHCP Management EG, LLC | 10% Owner | 5,089,354Indirect | Mar 27, 2026 | 1 |
| Feener Edward P. | CHIEF SCIENTIFIC OFFICER | 72,858 | May 21, 2024 | 0 |
| Crockett Thomas Andrew | CEO | 211,203 | Feb 21, 2024 | 0 |
| Cha Albert | Director | 0 | Sep 28, 2023 | 0 |
| Smith Michael David | Senior VP, Development | – | May 19, 2022 | 0 |
| Edwards Martin | Director | – | Oct 4, 2021 | 0 |
| Soland Daniel B | Director | – | Oct 1, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 (view filing) | Feb 1 | 4 days | Crockett Thomas AndrewCEO | SSale | −10.0K | $16.22 | −$162.2K | −7.8%117.5K after | 2 lots |
| Feb 8, 2024 (view filing)8:11 PM ET | Feb 6-8 | 2 days | Koh Bong Y and 6 others10% Owner | PPurchase | +86.0K | $14.62 | +$1.26M | +1.8%4.82M after | 3 lots |
| Feb 16, 2024 (view filing) | Feb 14 | 2 days | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −39.9K | $15.01 | −$598.7K | −37.6%66.2K after | |
| Feb 16, 2024 (view filing) | Feb 14 | 2 days | Feener Edward P.CHIEF SCIENTIFIC OFFICER | SSale | −28.2K | $15.01 | −$422.8K | −28.2%71.7K after | |
| Feb 16, 2024 (view filing) | Feb 14 | 2 days | Crockett Thomas AndrewCEO | SSale | −58.4K | $15.01 | −$875.9K | −24.3%181.7K after | |
| Feb 16, 2024 (view filing) | Feb 14 | 2 days | Palleiko Benjamin LCFO, CBO | SSale | −40.9K | $15.01 | −$613.2K | −20.4%159.1K after | |
| Feb 21, 2024 (view filing) | Feb 20 | 1 day | Crockett Thomas AndrewCEO | SSale | −24.9K | $14.11 | −$351.2K | −10.5%211.2K after | |
| Feb 21, 2024 (view filing) | Feb 20 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −14.3K | $14.12 | −$201.8K | −21.3%52.9K after | |
| Feb 21, 2024 (view filing) | Feb 20 | 1 day | Palleiko Benjamin LCFO, CBO | SSale | −22.8K | $14.11 | −$321.7K | −10.9%187.3K after | |
| Feb 21, 2024 (view filing) | Feb 20 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −12.1K | $14.11 | −$170.1K | −14.2%72.9K after | |
| Feb 21, 2024 (view filing) | Feb 20 | 1 day | Feener Edward P.CHIEF SCIENTIFIC OFFICER | SSale | −28.3K | $14.07 | −$398.0K | −31.3%62.2K after | 3 lots10b5-1 |
| Feb 22, 2024 (view filing)4:15 PM ET | Feb 20 | 2 days | Koh Bong Y and 6 others10% Owner | PPurchase | +655.7K | $15.25 | +$10.0M | –655.7K after | Derivative |
| May 21, 2024 (view filing) | May 20 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −11.6K | $11.76 | −$136.5K | −12.7%80.1K after | |
| May 21, 2024 (view filing) | May 20 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −22.0K | $11.76 | −$258.2K | −9.2%216.4K after | |
| May 21, 2024 (view filing) | May 20 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −13.2K | $11.76 | −$154.9K | −15.8%70.3K after | |
| May 21, 2024 (view filing) | May 20 | 1 day | Feener Edward P.CHIEF SCIENTIFIC OFFICER | SSale | −8.09K | $11.76 | −$95.1K | −10.0%72.9K after | 10b5-1 |
| Jun 10, 2024 (view filing) | Jun 7 | 3 days | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −7.46K | $11.53 | −$86.1K | −3.2%224.5K after | |
| Aug 21, 2024 (view filing) | Aug 19 | 2 days | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −7.10K | $12.01 | −$85.3K | −7.8%84.5K after | |
| Aug 21, 2024 (view filing) | Aug 19 | 2 days | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −14.2K | $12.01 | −$170.7K | −5.5%242.5K after | |
| Aug 21, 2024 (view filing) | Aug 19 | 2 days | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −7.97K | $12.01 | −$95.8K | −9.0%80.9K after | |
| Aug 26, 2024 (view filing) | Aug 23 | 3 days | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −1.92K | $12.40 | −$23.8K | −2.2%85.7K after | |
| Aug 26, 2024 (view filing) | Aug 23 | 3 days | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −2.13K | $12.40 | −$26.5K | −2.5%83.7K after | |
| Sep 10, 2024 (view filing) | Sep 9 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −7.35K | $12.19 | −$89.6K | −2.8%250.8K after | |
| Nov 19, 2024 (view filing) | Nov 18 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −8.08K | $9.26 | −$74.8K | −7.9%94.2K after | |
| Nov 19, 2024 (view filing) | Nov 18 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −7.19K | $9.26 | −$66.6K | −7.4%90.0K after | |
| Nov 19, 2024 (view filing) | Nov 18 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −14.4K | $9.26 | −$133.3K | −5.1%266.6K after | |
| Nov 27, 2024 (view filing) | Nov 26 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −1.96K | $9.87 | −$19.4K | −2.1%91.1K after | |
| Nov 27, 2024 (view filing) | Nov 26 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −2.19K | $9.87 | −$21.6K | −2.2%97.0K after | |
| Dec 9, 2024 (view filing) | Dec 9 | Same day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −7.63K | $9.75 | −$74.4K | −2.7%274.6K after | |
| Feb 3, 2025 (view filing)7:42 PM ET | Jan 30-Feb 3 | 4 days | Koh Bong Y and 6 others10% Owner | PPurchase | +70.0K | $8.88 | +$621.6K | +1.4%5.01M after | 3 lots |
| Feb 11, 2025 (view filing)7:51 PM ET | Feb 7-11 | 4 days | Koh Bong Y and 6 others10% Owner | PPurchase | +104.5K | $9.26 | +$967.1K | +2.1%5.12M after | 3 lots |
| Feb 14, 2025 (view filing)7:45 PM ET | Feb 12-13 | 2 days | Koh Bong Y and 6 others10% Owner | PPurchase | +161.7K | $9.27 | +$1.50M | +3.2%5.28M after | 2 lots |
| Feb 19, 2025 (view filing) | Feb 18 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −5.10K | $9.82 | −$50.1K | −1.8%278.9K after | |
| Feb 19, 2025 (view filing) | Feb 18 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −3.13K | $9.82 | −$30.7K | −3.0%100.3K after | |
| Feb 19, 2025 (view filing) | Feb 18 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −2.60K | $9.82 | −$25.5K | −2.7%92.7K after | |
| Feb 25, 2025 (view filing) | Feb 24 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −1.92K | $10.02 | −$19.2K | −2.0%94.0K after | |
| Feb 25, 2025 (view filing) | Feb 24 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −2.39K | $10.02 | −$24.0K | −2.3%102.9K after | |
| Mar 10, 2025 (view filing) | Mar 7 | 3 days | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −6.67K | $11.97 | −$79.8K | −2.3%287.8K after | |
| Apr 11, 2025 (view filing)5:22 PM ET | Apr 9 | 2 days | Koh Bong Y and 6 others10% Owner | PPurchase | +25.0K | $9.42 | +$235.5K | +0.5%5.30M after | |
| May 20, 2025 (view filing) | May 19 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −2.78K | $11.84 | −$32.9K | −2.5%106.6K after | |
| May 20, 2025 (view filing) | May 19 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −3.81K | $11.84 | −$45.1K | −1.3%293.4K after | |
| May 20, 2025 (view filing) | May 19 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −2.60K | $11.84 | −$30.8K | −2.6%95.6K after | |
| May 23, 2025 (view filing) | May 22 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −10.0K | $11.88 | −$118.8K | −3.2%306.6K after | |
| May 23, 2025 (view filing) | May 22 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −2.32K | $11.88 | −$27.5K | −2.3%97.0K after | |
| May 23, 2025 (view filing) | May 22 | 1 day | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −2.69K | $11.88 | −$31.9K | −2.4%110.2K after | |
| May 27, 2025 (view filing) | May 23 | 4 days | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −1.93K | $11.31 | −$21.8K | −1.9%98.2K after | |
| May 27, 2025 (view filing) | May 23 | 4 days | Audhya Paul K.CHIEF MEDICAL OFFICER | SSale | −2.15K | $11.31 | −$24.3K | −1.9%113.0K after | |
| Jun 10, 2025 (view filing) | Jun 9 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −7.17K | $14.50 | −$104.0K | −2.2%315.1K after | |
| Jul 10, 2025 (view filing) | Jul 9 | 1 day | Yea ChristopherCHIEF DEVELOPMENT OFFICER | SSale | −30.3K | $15.69 | −$474.6K | −19.1%127.9K after | |
| Jul 10, 2025 (view filing) | Jul 9 | 1 day | Palleiko Benjamin LCHIEF EXECUTIVE OFFICER | SSale | −33.0K | $15.69 | −$517.4K | −8.2%369.6K after |